Stifel raises Zimmer Biomet price target to $140
The target increase is bullish, but analyst targets are opinions and the prior target was not provided.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target increase is bullish, but analyst targets are opinions and the prior target was not provided.
What happened, with direct paths to the underlying reporting
Stifel raised its ZBH price target to $140; the cited share price was $103.21, implying roughly 36% upside to the target.
Target: $140
Posted price: $103.21
Analyst firm: Stifel Nicolaus
Analyst: Rick Wise
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.